2 April 2025CompletedHealthcare
Johnson & Johnson to acquire Intra-Cellular Therapies, Inc.
Johnson & Johnson and Intra-Cellular Therapies, Inc. entered the Exit Mode archive.
- Buyer
- Johnson & Johnson
- Target
- Intra-Cellular Therapies, Inc.
- Deal value
- USD 14,600,000,000
- Deal type
- going private
